Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer-Reference-Cited by-同舟云学术

Quality-of-life findings from a randomised phase-III study of XELOX vs FOLFOX-6 in metastatic colorectal cancer

Published:2009-11-17 Issue:1 Volume:102 Page:59-67
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Conroy T,Hebbar M,Bennouna J,Ducreux M,Ychou M,Llédo G,Adenis A,Faroux R,Rebischung C,Kockler L,Douillard J Y

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6605442.pdf

Reference42 articles.

1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376

2. American Society of Clinical Oncology (1996) Outcomes of cancer treatment for technology assessment and cancer treatment guidelines. J Clin Oncol 14: 671–679

3. Beitz J, Gnecco C, Justice R (1996) Quality-of-life end points in cancer clinical trials: the US Food and Drug Administration perspective. J Natl Cancer Inst Monogra 20: 7–9

4. Borner MM, Schoffski P, de Wit R, Caponigro F, Comella G, Sulkes A, Greim G, Peters GJ, van der Born K, Wanders J, de Boer RF, Martin C, Fumoleau P (2002) Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: a randomised crossover trial in advanced colorectal cancer. Eur J Cancer 38: 349–358

5. Boyle P, Ferlay J (2005) Cancer incidence and mortality in Europe, 2004. Ann Oncol 16: 481–488

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optimal duration of oxaliplatin-based adjuvant chemotherapy in patients with different risk factors for stage II-III colon cancer: a meta-analysis;International Journal of Surgery;2024-02-13

2. Impacts of systemic treatments on health-related quality of life for patients with metastatic colorectal cancer: a systematic review and network meta-analysis;BMC Cancer;2024-02-09

3. Efficacy of neoadjuvant CapeOX/mFOLFOX6 without radiation for patients with baseline resectable mid–low locally advanced rectal cancer;Journal of Digestive Diseases;2022-12

4. Postoperative radiotherapy for thymus salivary gland carcinoma: A case report;World Journal of Clinical Cases;2022-09-16

5. Quality of life in a randomized trial comparing two neoadjuvant regimens for locally advanced rectal cancer—INCAGI004;Supportive Care in Cancer;2022-04-29